CoreCap Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
WCM
TCM
ASG
FWP
HWP
CoreCap Advisors's BCAT Position: Q3 2026 in Review
CoreCap Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 29% in Q3 2026, buying an estimated $218K and bringing the position to 62,291 shares worth $853K. The position accounts for 0.02% of the portfolio, ranked #417.
CoreCap Advisors first reported a position in BCAT in Q4 2022 and has held it in 12 quarters since. 9 funds tracked by Wall St. Rank hold BCAT as of Q3 2026.
- CoreCap Advisors held 62,291 shares of BlackRock Capital Allocation Term Trust worth $853K as of Q3 2026.
- CoreCap Advisors bought 14,145 BlackRock Capital Allocation Term Trust shares in Q3 2026, an estimated $218K.
- BlackRock Capital Allocation Term Trust made up 0.02% of CoreCap Advisors's portfolio in Q3 2026, its #417 holding.
- CoreCap Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and has held it in 12 quarters since.
- 9 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2026.
Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.